Javascript must be enabled to continue!
Antiarrhythmics
View through CrossRef
Abstract
Antiarrhythmic drugs are the cornerstone of supraventricular and ventricular arrhythmias therapy. Despite the increasing interest in invasive and ablative approaches to treating many arrhythmias, such as atrial fibrillation and ventricular tachycardia, antiarrhythmic drugs are still widely used for both acute management and chronic prophylaxis. Unfortunately, many antiarrhythmic drugs currently available have a narrow therapeutic window and many issues regarding potential serious adverse effects, proarrhythmic properties, and multiorgan toxicity. The current Vaughan Williams classification of antiarrhythmic drugs is shown in a table. The aim this chapter is to provide basic information regarding the most used compounds in clinical practice.
Oxford University PressOxford
Title: Antiarrhythmics
Description:
Abstract
Antiarrhythmic drugs are the cornerstone of supraventricular and ventricular arrhythmias therapy.
Despite the increasing interest in invasive and ablative approaches to treating many arrhythmias, such as atrial fibrillation and ventricular tachycardia, antiarrhythmic drugs are still widely used for both acute management and chronic prophylaxis.
Unfortunately, many antiarrhythmic drugs currently available have a narrow therapeutic window and many issues regarding potential serious adverse effects, proarrhythmic properties, and multiorgan toxicity.
The current Vaughan Williams classification of antiarrhythmic drugs is shown in a table.
The aim this chapter is to provide basic information regarding the most used compounds in clinical practice.
Related Results
Monitoring Disopyramide, Lidocaine, and Quinidine by Micellar Liquid Chromatography
Monitoring Disopyramide, Lidocaine, and Quinidine by Micellar Liquid Chromatography
Abstract
A micellar liquid chromatography (MLC) method using a C18 column was developed to determine three antiarrhythmic drugsdisopyramide, lidocaine, and quinidine...
Abstract 18990: Impact of Cavotricuspid Isthmus Dependent Right Atrial Flutter Ablation on the Incidence and Recurrence of Atrial Fibrillation
Abstract 18990: Impact of Cavotricuspid Isthmus Dependent Right Atrial Flutter Ablation on the Incidence and Recurrence of Atrial Fibrillation
Background:
There is limited data evaluating the impact of cavotricuspid isthmus ablation for right Atrial Flutter (AFL) on the a) development of Atrial Fibrillation (A...
Atypical atrial flutter ablation: follow-up and predictors of arrhythmia recurrence
Atypical atrial flutter ablation: follow-up and predictors of arrhythmia recurrence
AbstractBackground: Ablation techniques have evolved greatly with advances in high-density 3D mapping systems over the last few years. Some patients develop atypical atrial flutter...
Prescription profile of antiarrhythmic drugs in a group of patients in Colombia
Prescription profile of antiarrhythmic drugs in a group of patients in Colombia
Objective: To determine the prescription patterns of antiarrhythmic drugs and variables associated with their use in a population of patients affiliated with the Colombian Health S...
Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis
Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis
Takotsubo syndrome (TTS) represents a form of acute heart failure featured by reversible left ventricular systolic dysfunction. The management during the acute phase is mainly perf...
AIHEMAF–P: An Innovative Healthcare Model for Atrial Fibrillation Patients
AIHEMAF–P: An Innovative Healthcare Model for Atrial Fibrillation Patients
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias of clinical relevance and a major cause of cardiovascular morbidity and mortality. Following a diagnosis of A...
Ion Channel Remodelling in Atrial Fibrillation
Ion Channel Remodelling in Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia and is associated with substantial cardiovascular morbidity and mortality, with stroke being the most critical complication. ...
Cardiovascular Medications
Cardiovascular Medications
Multiple classes of xenobiotics have the potential to influence the function of the cardiovascular system. When evaluating the hemodynamic consequences of any toxic exposure and in...

